Financial forecast （full year plan）
Plan for the Fiscal Year Ending April 30, 2026（revised plan)
Groupwide
In the whole company, the group forecasts net sales of￥646,000 million, increase 41.4% YoY, and ordinary profit of￥26,500 million, increase 46.6% YoY, due to the revision of the pharmacy business results from the contribution of Sakura Pharmacy Group.
| FY4/25 results |
FY4/26 initial plan |
FY4/26 revised plan |
YoY change |
YoY change(%) |
|
|---|---|---|---|---|---|
| Net sales | 456,804 | 522,000 | 646,000 | ＋41.4 | ＋23.8 |
| Gross profit % of net sales |
74,436 16.3 |
93,323 17.9 |
109,740 17.0 |
＋47.4 | ＋17.6 |
|
SG&A expenses % of net sales |
57,565 12.6 |
71,463 13.7 |
81,440 12.6 |
＋41.5 | ＋14.0 |
| Operating profit % of net sales |
16,871 3.7 |
21,860 4.2 |
28,300 4.4 |
＋67.7 | ＋29.5 |
| Ordinary profit % of net sales |
18,080 4.0 |
22,100 4.2 |
26,500 4.1 |
＋46.6 | ＋19.9 |
| Profit attributable to owners of parent % of net sales |
9,261 2.0 |
11,450 2.2 |
13,500 2.1 |
＋45.8 | ＋17.9 |
| Profit per share(¥) | 264.32 | 326.46 | 384.91 | ＋45.6 | ＋17.9 |
| EBITDA | 31,040 | 39,170 | 50,980 | ＋64.2 | ＋30.2 |
| Annual dividend (¥) | 80.00 | 80.00 | 80.00 | 0.0 | 0.0 |
▶Figures in the table are rounded down
Dispensing Pharmacy Business
In the dispensing pharmacy business, the group forecasts net sales of ￥551,500 million, increase 43.3% YoY, and segment profit of ￥32,300 million, increase 33.0% YoY due to the contribution of Sakura Pharmacy Group that joined the Group.
| FY4/25 results |
FY4/26 initial plan |
FY4/26 revised plan |
YoY change |
YoY change(%) |
|
|---|---|---|---|---|---|
| Net sales | 384,783 | 427,500 | 551,500 | +43.3 | +29.0 |
| Gross profit % of net sales |
40,485 10.5 |
46,270 10.8 |
62,670 11.4 |
+54.8 | +35.4 |
|
SG&A expenses % of net sales |
17,708 4.6 |
20,200 4.7 |
29,760 5.4 |
+68.1 | +47.3 |
| Operating profit % of net sales |
22,776 5.9 |
26,070 6.1 |
32,910 6.0 |
+44.5 | +26.2 |
| Segment profit % of net sales |
24,286 6.3 |
26,810 6.3 |
32,300 5.9 |
+33.0 | +20.5 |
▶Figures in the table are rounded down
▶Segment profit is adjusted with the ordinary profit of consolidated statements of income
Retail Business
In the retail business, the group forecasts net sales of ￥83,100 million, increase 36.1% YoY, and segment profit of ￥7,500 million, increase 56.1% YoY, due to the sales of AINZ&TULPE remained firm, in addition to the Francfranc contribution to the full year.
| FY4/25 results |
FY4/26 initial plan |
FY4/26 revised plan |
YoY change |
YoY change(%) |
|
|---|---|---|---|---|---|
| Net sales | 61,041 | 83,100 | 83,100 | +36.1 | 0.0 |
| Gross profit % of net sales |
30,030 49.2 |
43,090 51.9 |
43,090 51.9 |
+43.5 | 0.0 |
|
SG&A expenses % of net sales |
25,248 41.4 |
35,590 42.8 |
35,590 42.8 |
+41.0 | 0.0 |
| Operating profit % of net sales |
4,782 7.8 |
7,500 9.0 |
7,500 9.0 |
+56.8 | 0.0 |
| Segment profit % of net sales |
4,804 7.9 |
7,500 9.0 |
7,500 9.0 |
+56.1 | 0.0 |
▶Figures in the table are rounded down
▶Segment profit is adjusted with the ordinary profit of consolidated statements of income